Metformin inhibits high glucose-induced apoptosis of renal podocyte through regulating miR-34a/SIRT1 axis

被引:0
|
作者
Zhuang, Xudong [1 ]
Sun, Zhuye [2 ]
Du, Huasheng [3 ]
Zhou, Tianhui [4 ]
Zou, Jing [1 ]
Fu, Wei [5 ,6 ]
机构
[1] Linyi Tradit Chinese Med Hosp, Dept Dialysis, Linyi, Shandong, Peoples R China
[2] Rizhao Hosp Tradit Chinese Med, Dept Pharm, Rizhao, Shandong, Peoples R China
[3] Qingdao Municipal Hosp, Dept Nephrol, Qingdao, Shandong, Peoples R China
[4] Beijing Univ Chinese Med, Beijing, Peoples R China
[5] Zibo Cent Hosp, Dept Drug Dispensing, Zibo, Shandong, Peoples R China
[6] Zibo Cent Hosp, Dept Drug Dispensing, 54 Gongqingtuanxi Rd, Zibo 255036, Shandong, Peoples R China
关键词
DN; metformin; miR-34a; podocyte; SIRT1; DIABETIC-NEPHROPATHY; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; MICRORNA-34A; MICROALBUMINURIA; HYPERGLYCEMIA; HYPERTROPHY; CELLS; MICE;
D O I
10.1002/iid3.1053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundPrevious studies have reported SIRT1 was inversely modulated by miR-34a, However, mechanism of metformin (MFN)'s renal podocyte protection under high glucose (HG) conditions and the connection between miR-34a and SIRT1 expression in diabetic nephropathy (DN) remain unclear.MethodWe aimed to further elucidate the role of miR-34a in HG-treated podocytes in DN. A conditionally immortalized human podocyte cell line was cultivated in d-glucose (30 mM).ResultsMicroarray and RT-qPCR revealed that miR-34a was downregulated in HG-treated podocytes. Additionally, miR-34a levels increased in MFN-treated HG-induced podocytes. CCK-8 assay, colony formation assay, flow cytometry, and Western blot detection showed that HG treatment reduced cell viability and promoted via HG treatment, and MFN treatment reversed this phenotypic change. MiR-34a upregulation caused restored cell viability and suppressed cell apoptosis in HG-treated podocytes, and miR-34a downregulation led to damaged cell survival and induced apoptosis in MFN-administered and HG-treated podocytes. The dual luciferase reporter assay showed that SIRT1 3 '-UTR was a direct miR-34a target. Further studies demonstrated an elevation in SIRT1 levels in HG-exposed podocytes, whereas MFN treatment decreased SIRT1 levels. In addition, miR-34a upregulation led to reduced SIRT1 expression, whereas miR-34a inhibition increased SIRT1 levels in cells. MFN-induced miR-34a suppresses podocyte apoptosis under HG conditions by acting on SIRT1.ConclusionThis study proposes a promising approach to interpret the mechanisms of action of the MFN-miR-34a axis involved in DN. Our experimental results show that HG stimulation upregulated miR-34a and suppressed cell viability by upregulating apoptosis in podocytes. MFN attenuates HG-stimulated cell death in podocytes by downregulating miR-34a. Additionally, our data showed that SIRT1 expression was positively correlated with MFN treatment and inversely correlated with miR-34a expression.image
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis
    Xu, Jiang
    Chen, Yan
    Xing, Yan
    Ye, Shandong
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (09) : 813 - 820
  • [12] Circ-NCX1 inhibits LPS-induced chondrocyte apoptosis by regulating the miR-133a/SIRT1 axis
    Liu, Kai
    Fan, Xiao-E
    Zhang, Li
    Yang, Ying
    Zhou, Xiao-Ling
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (10): : 992 - 1000
  • [13] LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
    Chu, Jie
    Li, Hongle
    Xing, Yurong
    Jia, Jinlin
    Sheng, Jinxiu
    Yang, Lijun
    Sun, Kaiyan
    Qu, Yunhui
    Zhang, Yan
    Yin, Huiqing
    Wa, Junhu
    He, Fucheng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
  • [14] Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation
    Faridvand, Yousef
    Kazemzadeh, Hamid
    Vahedian, Vahid
    Mirzajanzadeh, Pourya
    Nejabati, Hamid Reza
    Safaie, Nasser
    Maroufi, Nazila Fathi
    Pezeshkian, Masoud
    Nouri, Mohammad
    Jodati, Ahmadreza
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (06) : 643 - 651
  • [15] The p53/miR-34a/SIRT1 Positive Feedback Loop in Quercetin-Induced Apoptosis
    Lou, Guohua
    Liu, Yanning
    Wu, Shanshan
    Xue, Jihua
    Yang, Fan
    Fu, Haijing
    Zheng, Min
    Chen, Zhi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (06) : 2192 - 2202
  • [16] 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop
    Xia, Caixia
    Shui, Liyan
    Lou, Guohua
    Ye, Bingjue
    Zhu, Wei
    Wang, Jing
    Wu, Shanshan
    Xu, Xiao
    Mao, Long
    Xu, Wanhong
    Chen, Zhi
    Liu, Yanning
    Zheng, Min
    SCIENTIFIC REPORTS, 2017, 7
  • [17] 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop
    Caixia Xia
    Liyan Shui
    Guohua Lou
    Bingjue Ye
    Wei Zhu
    Jing Wang
    Shanshan Wu
    Xiao Xu
    Long Mao
    Wanhong Xu
    Zhi Chen
    Yanning Liu
    Min Zheng
    Scientific Reports, 7
  • [19] Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK
    Rogacka, Dorota
    Audzeyenka, Irena
    Rychlowski, Michal
    Rachubik, Patrycja
    Szrejder, Maria
    Angielski, Stefan
    Piwkowska, Agnieszka
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (01): : 115 - 125
  • [20] miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells
    Lai, Mingguang
    Du, Gang
    Shi, Ruiyue
    Yao, Jun
    Yang, Genhua
    Wei, Yue
    Zhang, Dingguo
    Xu, Zhenglei
    Zhang, Ru
    Li, Yingxue
    Li, Zicheng
    Wang, Lisheng
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3301 - 3307